Simon Verdonck

PhD fellow at @FWOVlaanderen - Jonathan Maelfait's Lab @UGent @InflamResCen @VIBLifeSciences - Nucleic acid immunity & cell death

[Nature Rev Immunol @NatRevImmunol]

Novel insights into double-stranded RNA-mediated immunopathology https://t.co/IV5JyDLa3D

[Immunobiology2025@UNIL @Immunobiology22]

Congratulations to @DBertheloot (from @UniBonn), @VerdonckSimon (from @ugent) & @CassHarapas (from @WEHI_research) for winning the poster prizes!
And thanks a lot to everyone who shared their research and enganged in scientific discussions throughout the meeting!
#Immunobiology22

[Immunology Podcast @ImmunoPodcast]

This week: Jonathan Maelfait's lab at @InflamResCen showed that ADAR1 inhibits the spontaneous activation of ZBP1, preventing #autoinflammation.

1st authors: Richard de Reuver & Simon Verdonck (@VerdonckSimon)

📍 @Nature: https://t.co/phVy2nQoxr
🎙️: https://t.co/QOZU6oMTI0

[Nature Reviews Genetics @NatureRevGenet]

DISEASE GENETICS: ADAR1 inhibits ZBP1 activation by endogenous Z-RNA https://t.co/lOrWc2zKhj #ResearchHighlight

[Simon Verdonck @VerdonckSimon]

So proud to share our latest work on ADAR1 preventing autoinflammatory responses by negatively regulating ZBP1. A huge team effort! @VIBLifeSciences @InflamResCen @Nature

https://t.co/necwYUooqp

[John Lukens @LukensJohnR]

3 great papers identifying ADAR1 as a negative regulator of endogenous ZBP1 activation and type I interferonopathies @nature
https://t.co/asOfUyGVRb
https://t.co/336RGRWJvm
https://t.co/XNbNRBd275

[Simon Verdonck @VerdonckSimon]

@maschalidi @Nature Beautiful work, congratulations Sophia!

[Trends in Microbiology @TrendsMicrobiol]

Out online now: Simon Verdonck and colleagues discuss how #viruses manipulate host necroptosis and pyroptosis and promote their spread.
@VIBLifeSciences @InflamResCen @JNemegeer @VerdonckSimon

https://t.co/GUGxXtp05w

[Prof. Shane Crotty @profshanecrotty]

1/ Are RNA vaccines safe? I have gotten this question a lot lately, and it is a good question.

[Oded Rechavi @OdedRechavi]

How a GFP tag feels

[New York Times Opinion @nytopinion]

Concerns about the staying power of Covid-19 immunity “are confused and mistaken,” write @VirusesImmunity and @RMedzhitov https://t.co/s243mF4NqU

[bart lambrecht @bart_lambrecht]

heads-up for new paper from @BosteelsCedric in @ImmunityCP. using 2 respiratory viruses & scRNAseq to dissect APC. New type of inflammatory cDC2 has IRF8 like cDC1 and Fc receptors like MF. It uses convalescent plasma to boost CD4, and looks like moDC. https://t.co/cBpXjo8apL

[Saskia Lippens @SasLippens]

Coronavirus doesn’t take the weekend off. The same is true for these volunteers for COVID-19 testing. They just keep on going. Great work ��@VIBLifeSciences⁩ ⁦@InflamResCen⁩ ⁦@VIB_CMB⁩ ⁦@ugent⁩ ⁦@uzgent⁩ ⁦@Biogazelle⁩

[David R. Liu @davidrliu]

Study of 206 monoclonal antibodies against #SARSCoV2 isolated from 8 #COVID19 patients. Some antibody clones are highly effective at neutralizing live SARS-CoV-2 virus in cells, suggesting that we now know human antibody sequences that would be effective COVID-19 drugs. (1/2)

[Prof. Akiko Iwasaki @VirusesImmunity]

There is a lot of talk about #herdimmunity. Vaccination is the only safe way to achieve it. In the absence of vaccine, we need to practice #SocialDistancing. @BioRender made this amazing infographic to explain how a hypothetical virus spreads through the population. (1/n)